Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Congenital Heart Disease Revenue 1.4 Market Analysis by Type 1.4.1 Global Congenital Heart Disease Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Medications 1.4.3 Implantable heart devices 1.4.4 Catheter procedures 1.4.5 Open-heart surgery 1.4.6 Heart transplant 1.5 Market by Application 1.5.1 Global Congenital Heart Disease Market Share by Application: 2020 VS 2026 1.5.2 Hospitals and clinics 1.5.3 Diagnostic centres 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Congenital Heart Disease Market Perspective (2015-2026) 2.2 Congenital Heart Disease Growth Trends by Regions 2.2.1 Congenital Heart Disease Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Congenital Heart Disease Historic Market Share by Regions (2015-2020) 2.2.3 Congenital Heart Disease Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Congenital Heart Disease Market Growth Strategy 2.3.6 Primary Interviews with Key Congenital Heart Disease Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Congenital Heart Disease Players by Market Size 3.1.1 Global Top Congenital Heart Disease Players by Revenue (2015-2020) 3.1.2 Global Congenital Heart Disease Revenue Market Share by Players (2015-2020) 3.1.3 Global Congenital Heart Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Congenital Heart Disease Market Concentration Ratio 3.2.1 Global Congenital Heart Disease Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Congenital Heart Disease Revenue in 2019 3.3 Congenital Heart Disease Key Players Head office and Area Served 3.4 Key Players Congenital Heart Disease Product Solution and Service 3.5 Date of Enter into Congenital Heart Disease Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Congenital Heart Disease Historic Market Size by Type (2015-2020) 4.2 Global Congenital Heart Disease Forecasted Market Size by Type (2021-2026) 5 Congenital Heart Disease Breakdown Data by Application (2015-2026) 5.1 Global Congenital Heart Disease Market Size by Application (2015-2020) 5.2 Global Congenital Heart Disease Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Congenital Heart Disease Market Size (2015-2020) 6.2 Congenital Heart Disease Key Players in North America (2019-2020) 6.3 North America Congenital Heart Disease Market Size by Type (2015-2020) 6.4 North America Congenital Heart Disease Market Size by Application (2015-2020) 7 Europe 7.1 Europe Congenital Heart Disease Market Size (2015-2020) 7.2 Congenital Heart Disease Key Players in Europe (2019-2020) 7.3 Europe Congenital Heart Disease Market Size by Type (2015-2020) 7.4 Europe Congenital Heart Disease Market Size by Application (2015-2020) 8 China 8.1 China Congenital Heart Disease Market Size (2015-2020) 8.2 Congenital Heart Disease Key Players in China (2019-2020) 8.3 China Congenital Heart Disease Market Size by Type (2015-2020) 8.4 China Congenital Heart Disease Market Size by Application (2015-2020) 9 Japan 9.1 Japan Congenital Heart Disease Market Size (2015-2020) 9.2 Congenital Heart Disease Key Players in Japan (2019-2020) 9.3 Japan Congenital Heart Disease Market Size by Type (2015-2020) 9.4 Japan Congenital Heart Disease Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Congenital Heart Disease Market Size (2015-2020) 10.2 Congenital Heart Disease Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Congenital Heart Disease Market Size by Type (2015-2020) 10.4 Southeast Asia Congenital Heart Disease Market Size by Application (2015-2020) 11 India 11.1 India Congenital Heart Disease Market Size (2015-2020) 11.2 Congenital Heart Disease Key Players in India (2019-2020) 11.3 India Congenital Heart Disease Market Size by Type (2015-2020) 11.4 India Congenital Heart Disease Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Congenital Heart Disease Market Size (2015-2020) 12.2 Congenital Heart Disease Key Players in Central & South America (2019-2020) 12.3 Central & South America Congenital Heart Disease Market Size by Type (2015-2020) 12.4 Central & South America Congenital Heart Disease Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Abbott Diagnostics 13.1.1 Abbott Diagnostics Company Details 13.1.2 Abbott Diagnostics Business Overview and Its Total Revenue 13.1.3 Abbott Diagnostics Congenital Heart Disease Introduction 13.1.4 Abbott Diagnostics Revenue in Congenital Heart Disease Business (2015-2020)) 13.1.5 Abbott Diagnostics Recent Development 13.2 Array BioPharma 13.2.1 Array BioPharma Company Details 13.2.2 Array BioPharma Business Overview and Its Total Revenue 13.2.3 Array BioPharma Congenital Heart Disease Introduction 13.2.4 Array BioPharma Revenue in Congenital Heart Disease Business (2015-2020) 13.2.5 Array BioPharma Recent Development 13.3 AstraZeneca 13.3.1 AstraZeneca Company Details 13.3.2 AstraZeneca Business Overview and Its Total Revenue 13.3.3 AstraZeneca Congenital Heart Disease Introduction 13.3.4 AstraZeneca Revenue in Congenital Heart Disease Business (2015-2020) 13.3.5 AstraZeneca Recent Development 13.4 Becton Dickinson 13.4.1 Becton Dickinson Company Details 13.4.2 Becton Dickinson Business Overview and Its Total Revenue 13.4.3 Becton Dickinson Congenital Heart Disease Introduction 13.4.4 Becton Dickinson Revenue in Congenital Heart Disease Business (2015-2020) 13.4.5 Becton Dickinson Recent Development 13.5 BG Medicine 13.5.1 BG Medicine Company Details 13.5.2 BG Medicine Business Overview and Its Total Revenue 13.5.3 BG Medicine Congenital Heart Disease Introduction 13.5.4 BG Medicine Revenue in Congenital Heart Disease Business (2015-2020) 13.5.5 BG Medicine Recent Development 13.6 Bio-Rad 13.6.1 Bio-Rad Company Details 13.6.2 Bio-Rad Business Overview and Its Total Revenue 13.6.3 Bio-Rad Congenital Heart Disease Introduction 13.6.4 Bio-Rad Revenue in Congenital Heart Disease Business (2015-2020) 13.6.5 Bio-Rad Recent Development 13.7 Boston Scientific 13.7.1 Boston Scientific Company Details 13.7.2 Boston Scientific Business Overview and Its Total Revenue 13.7.3 Boston Scientific Congenital Heart Disease Introduction 13.7.4 Boston Scientific Revenue in Congenital Heart Disease Business (2015-2020) 13.7.5 Boston Scientific Recent Development 13.8 Covance 13.8.1 Covance Company Details 13.8.2 Covance Business Overview and Its Total Revenue 13.8.3 Covance Congenital Heart Disease Introduction 13.8.4 Covance Revenue in Congenital Heart Disease Business (2015-2020) 13.8.5 Covance Recent Development 13.9 Critical Diagnostics 13.9.1 Critical Diagnostics Company Details 13.9.2 Critical Diagnostics Business Overview and Its Total Revenue 13.9.3 Critical Diagnostics Congenital Heart Disease Introduction 13.9.4 Critical Diagnostics Revenue in Congenital Heart Disease Business (2015-2020) 13.9.5 Critical Diagnostics Recent Development 13.10 Roche 13.10.1 Roche Company Details 13.10.2 Roche Business Overview and Its Total Revenue 13.10.3 Roche Congenital Heart Disease Introduction 13.10.4 Roche Revenue in Congenital Heart Disease Business (2015-2020) 13.10.5 Roche Recent Development 13.11 GSK 10.11.1 GSK Company Details 10.11.2 GSK Business Overview and Its Total Revenue 10.11.3 GSK Congenital Heart Disease Introduction 10.11.4 GSK Revenue in Congenital Heart Disease Business (2015-2020) 10.11.5 GSK Recent Development 13.12 Janssen Pharmaceuticals 10.12.1 Janssen Pharmaceuticals Company Details 10.12.2 Janssen Pharmaceuticals Business Overview and Its Total Revenue 10.12.3 Janssen Pharmaceuticals Congenital Heart Disease Introduction 10.12.4 Janssen Pharmaceuticals Revenue in Congenital Heart Disease Business (2015-2020) 10.12.5 Janssen Pharmaceuticals Recent Development 13.13 Medtronic 10.13.1 Medtronic Company Details 10.13.2 Medtronic Business Overview and Its Total Revenue 10.13.3 Medtronic Congenital Heart Disease Introduction 10.13.4 Medtronic Revenue in Congenital Heart Disease Business (2015-2020) 10.13.5 Medtronic Recent Development 13.14 Merck 10.14.1 Merck Company Details 10.14.2 Merck Business Overview and Its Total Revenue 10.14.3 Merck Congenital Heart Disease Introduction 10.14.4 Merck Revenue in Congenital Heart Disease Business (2015-2020) 10.14.5 Merck Recent Development 13.15 Mylan 10.15.1 Mylan Company Details 10.15.2 Mylan Business Overview and Its Total Revenue 10.15.3 Mylan Congenital Heart Disease Introduction 10.15.4 Mylan Revenue in Congenital Heart Disease Business (2015-2020) 10.15.5 Mylan Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Congenital Heart Disease Key Market Segments Table 2. Key Players Covered: Ranking by Congenital Heart Disease Revenue Table 3. Ranking of Global Top Congenital Heart Disease Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Congenital Heart Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Medications Table 6. Key Players of Implantable heart devices Table 7. Key Players of Catheter procedures Table 8. Key Players of Open-heart surgery Table 9. Key Players of Heart transplant Table 10. Global Congenital Heart Disease Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Congenital Heart Disease Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Congenital Heart Disease Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Congenital Heart Disease Market Share by Regions (2015-2020) Table 14. Global Congenital Heart Disease Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Congenital Heart Disease Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Congenital Heart Disease Market Growth Strategy Table 20. Main Points Interviewed from Key Congenital Heart Disease Players Table 21. Global Congenital Heart Disease Revenue by Players (2015-2020) (Million US$) Table 22. Global Congenital Heart Disease Market Share by Players (2015-2020) Table 23. Global Top Congenital Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Heart Disease as of 2019) Table 24. Global Congenital Heart Disease by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Congenital Heart Disease Product Solution and Service Table 27. Date of Enter into Congenital Heart Disease Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Congenital Heart Disease Market Size by Type (2015-2020) (Million US$) Table 30. Global Congenital Heart Disease Market Size Share by Type (2015-2020) Table 31. Global Congenital Heart Disease Revenue Market Share by Type (2021-2026) Table 32. Global Congenital Heart Disease Market Size Share by Application (2015-2020) Table 33. Global Congenital Heart Disease Market Size by Application (2015-2020) (Million US$) Table 34. Global Congenital Heart Disease Market Size Share by Application (2021-2026) Table 35. North America Key Players Congenital Heart Disease Revenue (2019-2020) (Million US$) Table 36. North America Key Players Congenital Heart Disease Market Share (2019-2020) Table 37. North America Congenital Heart Disease Market Size by Type (2015-2020) (Million US$) Table 38. North America Congenital Heart Disease Market Share by Type (2015-2020) Table 39. North America Congenital Heart Disease Market Size by Application (2015-2020) (Million US$) Table 40. North America Congenital Heart Disease Market Share by Application (2015-2020) Table 41. Europe Key Players Congenital Heart Disease Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Congenital Heart Disease Market Share (2019-2020) Table 43. Europe Congenital Heart Disease Market Size by Type (2015-2020) (Million US$) Table 44. Europe Congenital Heart Disease Market Share by Type (2015-2020) Table 45. Europe Congenital Heart Disease Market Size by Application (2015-2020) (Million US$) Table 46. Europe Congenital Heart Disease Market Share by Application (2015-2020) Table 47. China Key Players Congenital Heart Disease Revenue (2019-2020) (Million US$) Table 48. China Key Players Congenital Heart Disease Market Share (2019-2020) Table 49. China Congenital Heart Disease Market Size by Type (2015-2020) (Million US$) Table 50. China Congenital Heart Disease Market Share by Type (2015-2020) Table 51. China Congenital Heart Disease Market Size by Application (2015-2020) (Million US$) Table 52. China Congenital Heart Disease Market Share by Application (2015-2020) Table 53. Japan Key Players Congenital Heart Disease Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Congenital Heart Disease Market Share (2019-2020) Table 55. Japan Congenital Heart Disease Market Size by Type (2015-2020) (Million US$) Table 56. Japan Congenital Heart Disease Market Share by Type (2015-2020) Table 57. Japan Congenital Heart Disease Market Size by Application (2015-2020) (Million US$) Table 58. Japan Congenital Heart Disease Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Congenital Heart Disease Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Congenital Heart Disease Market Share (2019-2020) Table 61. Southeast Asia Congenital Heart Disease Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Congenital Heart Disease Market Share by Type (2015-2020) Table 63. Southeast Asia Congenital Heart Disease Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Congenital Heart Disease Market Share by Application (2015-2020) Table 65. India Key Players Congenital Heart Disease Revenue (2019-2020) (Million US$) Table 66. India Key Players Congenital Heart Disease Market Share (2019-2020) Table 67. India Congenital Heart Disease Market Size by Type (2015-2020) (Million US$) Table 68. India Congenital Heart Disease Market Share by Type (2015-2020) Table 69. India Congenital Heart Disease Market Size by Application (2015-2020) (Million US$) Table 70. India Congenital Heart Disease Market Share by Application (2015-2020) Table 71. Central & South America Key Players Congenital Heart Disease Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Congenital Heart Disease Market Share (2019-2020) Table 73. Central & South America Congenital Heart Disease Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Congenital Heart Disease Market Share by Type (2015-2020) Table 75. Central & South America Congenital Heart Disease Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Congenital Heart Disease Market Share by Application (2015-2020) Table 77. Abbott Diagnostics Company Details Table 78. Abbott Diagnostics Business Overview Table 79. Abbott Diagnostics Product Table 80. Abbott Diagnostics Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 81. Abbott Diagnostics Recent Development Table 82. Array BioPharma Company Details Table 83. Array BioPharma Business Overview Table 84. Array BioPharma Product Table 85. Array BioPharma Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 86. Array BioPharma Recent Development Table 87. AstraZeneca Company Details Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Product Table 90. AstraZeneca Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 91. AstraZeneca Recent Development Table 92. Becton Dickinson Company Details Table 93. Becton Dickinson Business Overview Table 94. Becton Dickinson Product Table 95. Becton Dickinson Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 96. Becton Dickinson Recent Development Table 97. BG Medicine Company Details Table 98. BG Medicine Business Overview Table 99. BG Medicine Product Table 100. BG Medicine Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 101. BG Medicine Recent Development Table 102. Bio-Rad Company Details Table 103. Bio-Rad Business Overview Table 104. Bio-Rad Product Table 105. Bio-Rad Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 106. Bio-Rad Recent Development Table 107. Boston Scientific Company Details Table 108. Boston Scientific Business Overview Table 109. Boston Scientific Product Table 110. Boston Scientific Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 111. Boston Scientific Recent Development Table 112. Covance Business Overview Table 113. Covance Product Table 114. Covance Company Details Table 115. Covance Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 116. Covance Recent Development Table 117. Critical Diagnostics Company Details Table 118. Critical Diagnostics Business Overview Table 119. Critical Diagnostics Product Table 120. Critical Diagnostics Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 121. Critical Diagnostics Recent Development Table 122. Roche Company Details Table 123. Roche Business Overview Table 124. Roche Product Table 125. Roche Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 126. Roche Recent Development Table 127. GSK Company Details Table 128. GSK Business Overview Table 129. GSK Product Table 130. GSK Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 131. GSK Recent Development Table 132. Janssen Pharmaceuticals Company Details Table 133. Janssen Pharmaceuticals Business Overview Table 134. Janssen Pharmaceuticals Product Table 135. Janssen Pharmaceuticals Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 136. Janssen Pharmaceuticals Recent Development Table 137. Medtronic Company Details Table 138. Medtronic Business Overview Table 139. Medtronic Product Table 140. Medtronic Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 141. Medtronic Recent Development Table 142. Merck Company Details Table 143. Merck Business Overview Table 144. Merck Product Table 145. Merck Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 146. Merck Recent Development Table 147. Mylan Company Details Table 148. Mylan Business Overview Table 149. Mylan Product Table 150. Mylan Revenue in Congenital Heart Disease Business (2015-2020) (Million US$) Table 151. Mylan Recent Development Table 152. Research Programs/Design for This Report Table 153. Key Data Information from Secondary Sources Table 154. Key Data Information from Primary Sources List of Figures Figure 1. Global Congenital Heart Disease Market Share by Type: 2020 VS 2026 Figure 2. Medications Features Figure 3. Implantable heart devices Features Figure 4. Catheter procedures Features Figure 5. Open-heart surgery Features Figure 6. Heart transplant Features Figure 7. Global Congenital Heart Disease Market Share by Application: 2020 VS 2026 Figure 8. Hospitals and clinics Case Studies Figure 9. Diagnostic centres Case Studies Figure 10. Congenital Heart Disease Report Years Considered Figure 11. Global Congenital Heart Disease Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Congenital Heart Disease Market Share by Regions: 2020 VS 2026 Figure 13. Global Congenital Heart Disease Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Congenital Heart Disease Market Share by Players in 2019 Figure 16. Global Top Congenital Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Heart Disease as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Congenital Heart Disease Revenue in 2019 Figure 18. North America Congenital Heart Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Congenital Heart Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Congenital Heart Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Congenital Heart Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Congenital Heart Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Congenital Heart Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Congenital Heart Disease Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Abbott Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Abbott Diagnostics Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 27. Array BioPharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Array BioPharma Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 29. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. AstraZeneca Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 31. Becton Dickinson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Becton Dickinson Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 33. BG Medicine Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. BG Medicine Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 35. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Bio-Rad Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 37. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Boston Scientific Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 39. Covance Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Covance Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 41. Critical Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Critical Diagnostics Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 43. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Roche Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 45. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. GSK Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 47. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Janssen Pharmaceuticals Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 49. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Medtronic Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 51. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Merck Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 53. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Mylan Revenue Growth Rate in Congenital Heart Disease Business (2015-2020) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Abbott Diagnostics Array BioPharma AstraZeneca Becton Dickinson BG Medicine Bio-Rad Boston Scientific Covance Critical Diagnostics Roche GSK Janssen Pharmaceuticals Medtronic Merck Mylan